A Randomized Controlled Trial of Ambulatory Oxygen versus Air via Portable Concentrator in Chronic Interstitial Lung Disease

YH Khor, A Holland, N Goh, C McDonald - CHEST, 2020 - journal.chestnet.org
Online Supplement Page 1 Online Supplement Online supplements are not copyedited prior to
posting and the author(s) take full responsibility for the accuracy of all data. © 2020 AMERICAN …

Kurzfristige Effekte einer Sauerstoffsubstitution unter Belastung bei Patienten mit idiopathische pulmonaler Fibrose (IPF)

C Schneider - 2021 - archiv.ub.uni-marburg.de
Hintergrund: Bei hypoxischen Patienten mit idiopathischer pulmonaler Fibrose (IPF) wird in
den nationalen und internationalen Leitlinien eine Sauerstofftherapie unter Belastung …

The Role of Pulmonary Rehabilitation and Supplemental Oxygen Therapy in the Treatment of Patients with Idiopathic Pulmonary Fibrosis

C Wittman, JJ Swigris - Idiopathic Pulmonary Fibrosis: A Comprehensive …, 2019 - Springer
Pulmonary rehabilitation and supplemental oxygen therapy are two interventions commonly
employed as adjuncts to pharmacotherapy in the treatment of patients with idiopathic …

Health-related Quality of Life and its Associated Variables among Individuals with Idiopathic Pulmonary Fibrosis

M Bors - 2019 - search.proquest.com
Idiopathic pulmonary fibrosis (IPF) is a debilitating lung disease with a median survival of
only three to five years from the time of diagnosis, with no known cure, or treatment to extend …

Physiological mechanisms of dyspnoea in patients with fibrotic interstitial lung disease and the role of hyperoxia as an exercise intervention

MR Schaeffer - 2018 - open.library.ubc.ca
Problem: Dyspnoea is a common and debilitating symptom in patients with fibrotic interstitial
lung disease (ILD). Unfortunately, there are no therapies that consistently reduce exertional …

[PDF][PDF] An auto-titrating (intelligent) oxygen system in patients with chronic respiratory failure

MEUH Moghal - 2017 - core.ac.uk
Long-term oxygen therapy (LTOT) improves survival in patients with chronic obstructive
pulmonary disease (COPD) and chronic hypoxaemia with international guidelines …

The Hypoxic Adenosine Response Modulates Macrophage Differentiation and Contributes to Lung Disease

KM Philip - 2017 - digitalcommons.library.tmc.edu
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease which affects 5-8 million
individuals worldwide and 200,000 individuals in the United States alone. Although …

[HTML][HTML] ArtÃculos Especiales

C Codinardo, JO Cáneva, G Montiel, MEU Echevarría… - ramr.org
La hipoxemia crónica severa se define por la presencia de una presión parcial de oxígeno
arterial inferior a 60 mmHg. La oxigenoterapia, es decir el uso terapéutico del oxígeno …

Therapeutic interventions in interstitial lung disease: exercise training and supplemental oxygen

LM Dowman - 2016 - opal.latrobe.edu.au
Submission note: A thesis submitted in total fulfilment of the requirement for the degree of
Doctor of Philosophy, Discipline of Physiotherapy to the School of Allied Health, College of …

[PDF][PDF] Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire

V Cottin, P Bonniaud, J Cadranel, B Crestani… - Respir Med, 2014 - hal.science
La fibrose pulmonaire idiopathique (FPI) est la forme la plus fréquente de pneumopathie
interstitielle diffuse (PID) idiopathique chronique chez l'adulte, au sein du vaste groupe des …